Evidence map›Paper›PMID 33158906›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2021

Jelena Levi, Samuel Goth, Lyna Huynh, Tina Lam, Tony L Huynh, Brailee Schulte, Juliet A Packiasamy

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Challenges in tracer development for tumor microenvironment (TME) imaging.European journal of nuclear medicine and molecular imaging · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Imaging the fate of CAR-T cellsFrontiers in immunology · 2026
    Review
  7. [European journal of nuclear medicine and molecular imaging · 2025
    Article
  8. Approaches to Imaging Immune Activation Using PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Review
  9. Review
  10. Review
  11. Review
  12. [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  13. A Feasibility Study of [Molecular imaging and biology · 2024
    Article
  14. Total-Body Dynamic Imaging and Kinetic Modeling of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. [Communications biology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jelena LeviCellSight Technologies Incorporated, San Francisco, California; and jlevi@cellsighttech.com.
Samuel GothCellSight Technologies Incorporated, San Francisco, California; and.
Lyna HuynhCellSight Technologies Incorporated, San Francisco, California; and.
Tina LamCellSight Technologies Incorporated, San Francisco, California; and.
Tony L HuynhDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Brailee SchulteDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.
Juliet A PackiasamyCellSight Technologies Incorporated, San Francisco, California; and.
CellSight Technologies (United States) · USUniversity of California, San Francisco · US

Funding

NCI NIH HHS HHSN261201800024C
6 · The paper itself

Abstract

Most clinical trials exploring various combinations of chemo- and immunotherapy rely on serial biopsy to provide information on immune response. The aim of this study was to assess the value of

Indexed as

Fluorine RadioisotopesPositron-Emission TomographyAnimalsCD8-Positive T-LymphocytesCell DeathCell Line, TumorCyclophosphamideHumansImmunologic FactorsImmunotherapyMiceCyclophosphamideFluorine-18Fluorine RadioisotopesImmunologic FactorsCD8 T cellschemotherapyimmunomodulation

Identifiers

PMID33158906
PMCPMC8729865
OpenAlexW3095170233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.